Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study.

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. Leuk Lymphoma. 2012 Sep; 53(9):1743-8.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins
Disease-Free Survival
DNA Mutational Analysis
DNA-Binding Proteins
Female
Humans
Immunoglobulin Heavy Chains
Immunoglobulin Variable Region
Kaplan-Meier Estimate
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Mutation
Mutation, Missense
Polymorphism, Single Nucleotide
Proportional Hazards Models
Rituximab
Tumor Suppressor Proteins
Vidarabine

authors with profiles

Richard A. Larson